Journal of Peking University(Health Sciences) >
Comparative clinical study on seldom segment with multiple segment intramedullary primary spinal cord tumors
Received date: 2018-01-27
Online published: 2019-10-23
Supported by
Supported by the National Natural Science Foundation of China(81200969/H0912);the Grants from Science Foundation for the Excellent Youth Scholars of Ministry of Education of China(200800011035)
Objective: Several clinical studies were performed on multi-segment intramedullary primary spinal cord tumors. However, no clinical study focused on the relationship between different vertebral segments intramedullary tumors involvement and neurological functions, as well as prognosis of the patients. This prospective study was performed to compare clinical analysis on neurological functions and prognosis of the patients with intramedullary spinal cord primary tumors. Methods: A prospective cohort study was performed in a single medical center, Neurosurgical Department, Peking University Third Hospital. Between Jan. 1, 2010 and Dec. 30, 2015, 135 patients underwent microsurgery for intramedullary primary spinal cord tumors. The intramedullary tumor length occupying 3 or more vertebral body levels was considered as multiple segments intramedullary primary spinal cord tumor, and occupying one or two vertebral body levels considered as seldom segments. Preoperative and postoperative functions were assessed using IJOA (improved Japanese orthopaedic association) scoring system, and analyzed using the appropriate statistical tests. Results: Among the 135 patients, 52 cases had seldom segments intramedullary primary spinal cord tumors, and 83 cases had multiple segments. In the seldom group, 32 (62%) patients presented with normal urine and stool function, 8 (15%) patients with severe dysfunction, 7 (14%) with slight dysfunction, and 5 (9%) with incontinence, and 30 (58%) patients demonstrated various degrees of limbs weakness. The preoperative IJOA scores of the patients were 16.9±2.4. The postoperative IJOA scores at the end of 3 months were 16.6±2.3. The current IJOA scores until the end of the follow-up were 17.5±4.4. In the multiple group, 37 (45%) patients presented with normal urine and stool functions, 26 (31%) patients with slight dysfunction, 11 (13%) with severe dysfunction, and 9 (11%) with incontinence, and 62 (75%) patients demonstrated various degrees of limbs weakness. The preoperative IJOA scores of the patients were 15.6±3.4. The postoperative IJOA scores at the end of 3 months were 15.5±3.8. The current IJOA scores until the end of the follow-up were 16.9±5.8. The difference of presenting urine and stool dysfunction (Z=-1.35, P=0.18) was not statistically significant between the different patient groups. However, the difference of presenting limbs weakness (Z=-2.06, P=0.04) was statistically significant between the two groups. Most patients with multiple segment intramedullary tumors suffered from various limbs weakness. The difference of the preoperative IJOA score (P=0.02) and the postoperative early IJOA score (P=0.004) of the patients was statistically significant between the seldom and multiple segments groups. Preoperative and early postoperative neurological function of the patients was better with seldom segments tumor than with multiple segments tumor. Most patients with multi-segment intramedullary tumors experienced various limbs weakness. However, the difference of long-term neurological function (P=0.12) between the seldom and multiple segments groups was not statistically significant. The neurological function of the patients with multiple segments intramedullary tumor was remarkably improved after physical therapy. Conclusion: Perioperative neurological function of the patients with seldom segments primary tumor was superior to that of the patients with multiple segments primary tumor, especially for limb strength. The neurological function of the patients with multiple segments intramedullary primary tumor was remarkably improved after physical therapy during long-term follow-up.
Jian-jun SUN , Jun YANG , Jing-cheng XIE , Qing CHANG , Chang-cheng MA , Mei ZHENG , Hung-I LIAO , Tao WANG , Xiao-dong CHEN , Yun-feng HAN , Guo-zhong LIN , Tao YU , Jia ZHANG , Yu SI . Comparative clinical study on seldom segment with multiple segment intramedullary primary spinal cord tumors[J]. Journal of Peking University(Health Sciences), 2019 , 51(5) : 840 -850 . DOI: 10.19723/j.issn.1671-167X.2019.05.009
| [1] | Tobin MK, Geraghty JR, Engelhard HH , et al. Intramedullary spinal cord tumors: a review of current and future treatment strategies[J]. Neurosurg Focus, 2015,39(2):E14. |
| [2] | Acerbi F, Cavallo C, Schebesch KM , et al. Fluorescein-guided resection of intramedullary spinal cord tumors: results from a preliminary, multicentric, retrospective study[J]. World Neurosurg, 2017,108(10):603-609. |
| [3] | Montano N, Papacci F, Trevisi G , et al. Factors affecting functional outcome in patients with intramedullary spinal cord tumors: results from a literature analysis[J]. Acta Neurol Belg, 2017,117(1):277-282. |
| [4] | Sun JJ, Wang ZY, Li ZD , et al. Microsurgical treatment and functional outcomes of multi-segment intramedullary primary spinal cord tumors[J]. J Clin Neurosci, 2009,16(5):666-671. |
| [5] | Samuel N, Tetreault L, Santaguida C , et al. Clinical and pathological outcomes after resection of intramedullary spinal cord tumors: a single-institution case series[J]. Neurosurg Focus, 2016,41(2):E8. |
| [6] | Sun JJ, Sun ZY, Li ZD , et al. Clinical analysis of the adolescent patients with multi-segments intramedullary spinal cord tumors[J]. Beijing Da Xue Xue Bao Yi Xue Ban, 2012,44(4):599-601. |
| [7] | Wang ZY, Sun JJ, Xie JC , et al. Comparative analysis on the diagnosis and treatments of multi-segment intramedullary primary spinal cord tumors between the different age groups[J]. Neurosurg Rev, 2012,35(1):85-93. |
| [8] | Ebner FH, Roser F, Falk M , et al. Management of intramedullary spinal cord lesions: interdependence of the longitudinal extension of the lesion and the functional outcome[J]. Eur Spine J, 2010,19(4):665-669. |
| [9] | Ardeshiri A . Intramedullary spinal cord astrocytomas: the influence of localization and tumor extension on resectability and functional outcome[J]. Acta Neurochir, 2013,155(7):1203-1207. |
| [10] | Sharma NC, Chandra T, Sharma A , et al. Long-segment intramedullary spinal dermoid[J]. India J Radiol Imaging, 2009,19(2):148-150. |
| [11] | Bansal S, Ailawadhi P, Suri A , et al. Ten years’ experience in the management of spinal intramedullary tumors in a single institution[J]. J Clin Neurosci, 2013,20(2):292-298. |
| [12] | Raco A, Esposito V, Lenzi J , et al. Long-term follow-up of intramedullary primary spinal cord tumors: a series of 202 cases[J]. Neurosurgery, 2005,56(5):972-981. |
| [13] | Kutluk T, Varan A, Kafali C , et al. Pediatric intramedullary primary spinal cord tumors: a single center experience[J]. Eur J Paediatr Neurol, 2015,19(1):41-47. |
| [14] | Chang UK, Choe WJ, Chung SK , et al. Surgical outcome and prognostic factors of spinal intramedullary ependymomas in adults[J]. J Neurooncol, 2002,57(2):133-139. |
| [15] | Gavin QD, Farooqi N, Pigott TJ , et al. Outcome predictors in the management of spinal cord ependymoma[J]. Eur Spine J, 2007,16(3), 399-404. |
| [16] | Moquin RR . Cystic intramedullary neoplasms of the spinal cord[J]. Semin Spine Surg, 2006,18(3):168-174. |
| [17] | Xiao R . Molecular and clinical prognostic factors for favorable outcome following surgical resection of adult intramedullary spinal cord astrocytomas[J]. Clin Neurol Neurosurg, 2016,144(10):82-87. |
| [18] | Sun JJ, Teo M, Wang ZY , et al. Characteristic and surgical results of multisegment intramedullary cervical spinal cord tumors[J]. Interdisciplinary Neurosurgery, 2017,7:29-43. |
| [19] | Lee SM, Cho YE, Kwon YM . Neurological outcome after surgical treatment of intramedullary primary spinal cord tumors[J]. Korean J Spine, 2014,11(3):121-126. |
| [20] | Fakhreddine MH, Mahajan A, Penas-Prado M , et al. Treatment, prognostic factors, and outcomes in spinal cord astrocytomas[J]. Neuro Oncol, 2013,15(4):406-412. |
| [21] | Kim MS, Chung CK, Choe GY , et al. Intramedullary spinal cord astrocytoma in adults: postoperative outcome[J]. J Neuro Oncol, 2001,52(1):85-94. |
| [22] | Huddart R, Traish D, Ashley S , et al. Management of spinal astrocytoma with conservative surgery and radiotherapy. Br J Neurosurg, 1993,7(5):473-481. |
| [23] | Yang S, Yang X, Hong G . Surgical treatment of one hundred seventy-four intramedullary primary spinal cord tumors[J]. Spine, 2009,34(24), 2705-2710. |
| [24] | Abdullah KG, Lubelski D, Miller J , et al. Progression free survival and functional outcome after surgical resection of intramedullary ependymomas[J]. J Clin Neurosci, 2015,22(12):1933-1937. |
| [25] | Behmanesh B, Setzer M, Konczalla J , et al. Management of patients with primary intramedullary spinal cord glioblastoma[J]. World Neurosurg, 2017,98(10):198-202. |
| [26] | Jallo GI, Danish S, Velasquez L , et al. Intramedullary low-gradeastrocytomas: long-term outcome following radical surgery[J]. J Neurooncol, 2001,53(1):61-66. |
| [27] | Abd-El-Barr MM, Huang KT, Chi JH . Infiltrating spinal cord astrocytomas: Epidemiology, diagnosis, treatments and future directions[J]. J Clin Neurosci, 2016,29(7):15-20. |
| [28] | Venes J . Spinal cord astrocytoma: results of therapy[J]. Neurosurgery, 1992,30(4):490-493. |
| [29] | Schebesch KM, Mueller S, Wendl C , et al. Recurrence rates and functional outcome after resection of intrinsic intramedullary tumors[J]. Clin Neurol and Neurosurg, 2015,134(4):60-66. |
| [30] | Klekamp J . Treatment of intramedullary tumors: analysis of surgical morbidity and long-term results[J]. J Neurosurg Spine, 2013,19(1):12-26. |
| [31] | Sandler HM, Papadopoulos SM, Thornton AF , et al. Spinal cord astrocytomas: results of therapy[J]. Neurosurgery, 1992,30(4):490-493. |
/
| 〈 |
|
〉 |